- Home
- NMRA vs WSBF Comparison
NMRA vs WSBF Comparison
Compare NMRA & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- WSBF
- Stock Information
- Founded
- NMRA 2019
- WSBF 1921
- Country
- NMRA United States
- WSBF United States
- Employees
- NMRA N/A
- WSBF N/A
- Industry
- NMRA
- WSBF Savings Institutions
- Sector
- NMRA
- WSBF Finance
- Exchange
- NMRA Nasdaq
- WSBF Nasdaq
- Market Cap
- NMRA 287.6M
- WSBF 269.9M
- IPO Year
- NMRA 2023
- WSBF N/A
- Fundamental
- Price
- NMRA $1.16
- WSBF $13.81
- Analyst Decision
- NMRA Buy
- WSBF
- Analyst Count
- NMRA 8
- WSBF 0
- Target Price
- NMRA $10.14
- WSBF N/A
- AVG Volume (30 Days)
- NMRA 1.4M
- WSBF 37.0K
- Earning Date
- NMRA 03-03-2025
- WSBF 04-29-2025
- Dividend Yield
- NMRA N/A
- WSBF 4.33%
- EPS Growth
- NMRA N/A
- WSBF 118.94
- EPS
- NMRA N/A
- WSBF 1.01
- Revenue
- NMRA N/A
- WSBF $135,638,000.00
- Revenue This Year
- NMRA N/A
- WSBF N/A
- Revenue Next Year
- NMRA N/A
- WSBF N/A
- P/E Ratio
- NMRA N/A
- WSBF $13.69
- Revenue Growth
- NMRA N/A
- WSBF 3.74
- 52 Week Low
- NMRA $1.14
- WSBF $10.60
- 52 Week High
- NMRA $17.19
- WSBF $16.86
- Technical
- Relative Strength Index (RSI)
- NMRA 24.42
- WSBF 48.98
- Support Level
- NMRA $1.26
- WSBF $13.11
- Resistance Level
- NMRA $1.48
- WSBF $13.89
- Average True Range (ATR)
- NMRA 0.13
- WSBF 0.36
- MACD
- NMRA 0.06
- WSBF -0.03
- Stochastic Oscillator
- NMRA 5.77
- WSBF 56.91
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.